Researchers are excitedly focused on retatrutide, a innovative medication created by Eli Lilly, as a significant step in physique reduction . Distinct from many existing approaches, retatrutide is a dual -action compound targeting both GLP-1 and GIP, substances that influence satiety and blood gl